Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 27, 2022

Effectiveness of SGLT2 Inhibitors vs GLP-1RA on Cardiovascular Outcomes in Older Patients

Journal of the American Heart Association

 

Additional Info

Journal of the American Heart Association
Cardiovascular Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure
J Am Heart Assoc 2022 Feb 15;11(4)e022376, PT Htoo, J Buse, M Cavender, T Wang, V Pate, J Edwards, T Stürmer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading